Q2 2024 Holdings
Filed 2024-08-13 | 97 holdings | $246.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Grail Inc(GRAL) | COM | 384747101 | $3.7K | 240 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $34.7K | 2,000 | 0.0% |
| Kyverna Therapeutics(KYTX) | COM | 501976104 | $52.5K | 7,000 | 0.0% |
| Legend Biotech Corp(LEGN) | SPN ADR | 52490G102 | $88.6K | 2,000 | 0.0% |
| Perspective Therapeu(CATX) | COM | 46489V302 | $109.7K | 11,000 | 0.0% |
| Scholar Rock Hldg(SRRK) | COM | 80706P103 | $125.2K | 15,030 | 0.1% |
| PTC Therapeutics I(PTCT) | COM | 69366J200 | $131.5K | 4,300 | 0.1% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $135.4K | 3,900 | 0.1% |
| Summit Therapeutics(SMMT) | COM | 86627T108 | $195.0K | 25,000 | 0.1% |
| Arrowhead Pharmaceut(ARWR) | COM | 04280A100 | $195.5K | 7,522 | 0.1% |
| Halozyme Therapeutic(HALO) | COM | 40637H109 | $199.8K | 3,815 | 0.1% |
| Viatris Inc(VTRS) | COM | 92556V106 | $239.2K | 22,500 | 0.1% |
| Revolution Medicin(RVMD) | COM | 76155X100 | $256.1K | 6,600 | 0.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $257.5K | 11,460 | 0.1% |
| Crinetics Pharmace(CRNX) | COM | 22663K107 | $259.8K | 5,800 | 0.1% |
| Rocket Pharmaceutica(RCKT) | COM | 77313F106 | $269.8K | 12,530 | 0.1% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $279.2K | 7,718 | 0.1% |
| Madrigal Pharmaceuti(MDGL) | COM | 558868105 | $298.4K | 1,065 | 0.1% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $342.9K | 4,500 | 0.1% |
| Beigene Limited(ONC) | SPN ADR | 07725L102 | $349.1K | 2,447 | 0.1% |
| Sanofi(SNY) | SPN ADR | 80105N105 | $355.7K | 7,330 | 0.1% |
| Jazz Pharma PLC(JAZZ) | SHS USD | G50871105 | $355.8K | 3,334 | 0.1% |
| Ascendis Pharma A S(ASND) | SPN ADR | 04351P101 | $363.6K | 2,666 | 0.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $393.5K | 15,535 | 0.2% |
| Apellis Pharmaceutic(APLS) | COM | 03753U106 | $401.2K | 10,460 | 0.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $403.2K | 16,730 | 0.2% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $415.0K | 3,850 | 0.2% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $439.1K | 16,650 | 0.2% |
| Intra Cellular Thera(ITCIEUR) | COM | 46116X101 | $447.2K | 6,530 | 0.2% |
| Medpace Holdings(MEDP) | COM | 58506Q109 | $455.5K | 1,106 | 0.2% |
| Ionis Pharmaceutical(IONS) | COM | 462222100 | $460.4K | 9,660 | 0.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $485.8K | 45,957 | 0.2% |
| Structure Therapeu(GPCR) | SPN ADR | 86366E106 | $524.8K | 13,365 | 0.2% |
| Incyte Corporation(INCY) | COM | 45337C102 | $539.8K | 8,905 | 0.2% |
| Neurocrine Bioscienc(NBIX) | COM | 64125C109 | $541.7K | 3,935 | 0.2% |
| United Therapeutics(UTHR) | COM | 91307C102 | $579.8K | 1,820 | 0.2% |
| Illumina Inc(ILMN) | COM | 452327109 | $606.4K | 5,810 | 0.2% |
| Insmed Inc(INSM) | COM | 457669307 | $658.0K | 9,821 | 0.3% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $720.8K | 228,102 | 0.3% |
| Cogent Biosciences I(COGT) | COM | 19240Q201 | $721.6K | 85,600 | 0.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $927.2K | 34,830 | 0.4% |
| Becton Dickinson(BDX) | COM | 075887109 | $934.8K | 4,000 | 0.4% |
| Moonlake Immunothera(MLTX) | CLASS A ORD | 61559X104 | $942.2K | 21,428 | 0.4% |
| The Cigna Group(CI) | COM | 125523100 | $1.2M | 3,500 | 0.5% |
| Arcus Biosciences(RCUS) | COM USD | 03969F109 | $1.2M | 78,385 | 0.5% |
| Bristol Myers Squibb(BMY) | COM | 110122108 | $1.2M | 30,000 | 0.5% |
| Olema Pharmaceutical(OLMA) | COM | 68062P106 | $1.3M | 118,480 | 0.5% |
| Turnstone Biologics | COM | 90042W100 | $1.4M | 517,648 | 0.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.4M | 6,137 | 0.6% |
| Iteos Therapeutics(5E7) | COM | 46565G104 | $1.4M | 96,966 | 0.6% |